Zheng Liwen, Chairman of the Chinese Kuomintang, thanked and accepted the invitation of the Central Committee of the Communist Party of China and General Secretary Xi Jinping to lead a delegation to visit the mainland

Xinhua News Agency2026-03-30

Xinhua News Agency, Taipei, March 30 (Reporters Huang Yang and Jiang Jiang) The Office of the Chairman of the Chinese Kuomintang stated on the 30th that the Central Committee of the Communist Party of China and General Secretary Xi Jinping invited Chairman Zheng Liwen to lead a delegation to visit the mainland. Chairman Zheng expressed his gratitude and gladly accepted the invitation. It is hoped that the two parties will work together to promote the peaceful development of cross-Strait relations, promote cross-Strait exchanges and cooperation, seek peace in the Taiwan Strait, and improve people's livelihood.

Ministry of Foreign Affairs: We have lodged solemn representations with the United States regarding the U.S. Senator’s visit to Taiwan

2026-03-30

The Central Committee of the Communist Party of China and General Secretary Xi Jinping welcome and invite the delegation led by the Chairman of the Chinese Kuomintang Zheng Liwen to visit

2026-03-30

Zheng Liwen, Chairman of the Chinese Kuomintang, thanked and accepted the invitation of the Central Committee of the Communist Party of China and General Secretary Xi Jinping to lead a delegation to visit the mainland

2026-03-30

The 6th Consumer Expo will have more than 3,400 brands participating, with international exhibits accounting for 65%

2026-03-30

The 6th Consumer Expo will have more than 3,400 brands participating, with international exhibits accounting for 65%

2026-03-30

China's Ministry of National Defense sends a delegation to Europe to hold institutional dialogue

2026-03-29

In the first quarter of this year, my country’s innovative drug licensing transactions exceeded US$60 billion

2026-03-29

In the first three months of this year, the total number of external licensing transactions for my country’s innovative drugs exceeded US$60 billion.

2026-03-29